[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported an open-market sale of 97,289 shares of Class A common stock on March 17, 2026 at an average price of $24.69 per share. After this transaction, he continues to hold 407,282 shares directly.

According to a footnote, this sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2025, which means the trades were scheduled in advance rather than timed discretionarily.

Insights

Insider trading analyst

COO completes pre-planned sale, retains sizable stake.

Hims & Hers COO Michael Chi executed an open-market sale of 97,289 Class A shares at $24.69 per share on March 17, 2026, leaving him with 407,282 shares held directly.

A footnote states the sale followed a Rule 10b5-1 trading plan adopted on March 4, 2025. Such plans are set up in advance, so the timing offers limited signal about management’s short-term view, and the remaining position indicates continued exposure to the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chi Michael

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/17/2026		S(1)		97,289	D	$24.69	407,282	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Hims & Hers (HIMS) report for Michael Chi?

Hims & Hers reported that COO Michael Chi sold 97,289 shares of Class A common stock. The shares were sold in the open market at an average price of $24.69 per share, and he continues to hold 407,282 shares directly after the transaction.

When did the Hims & Hers (HIMS) COO sell his shares and at what price?

The COO’s sale occurred on March 17, 2026 at an average price of $24.69 per share. This was an open-market transaction involving 97,289 Class A common shares of Hims & Hers Health, Inc., as disclosed in the Form 4 filing.

How many Hims & Hers (HIMS) shares does COO Michael Chi hold after the sale?

After selling 97,289 shares, COO Michael Chi holds 407,282 shares of Hims & Hers Class A common stock directly. This remaining stake shows he maintains a substantial ownership position in the company following the disclosed open-market transaction.

Was the Hims & Hers (HIMS) COO’s share sale under a Rule 10b5-1 plan?

Yes. A footnote explains the sales were executed under a Rule 10b5-1 trading plan adopted on March 4, 2025. Such pre-arranged plans schedule trades in advance, reducing the significance of trade timing as a signal of insider sentiment.

What does a Rule 10b5-1 trading plan mean for Hims & Hers (HIMS) insider sales?

A Rule 10b5-1 plan allows insiders to pre-schedule trades while not in possession of material nonpublic information. For Hims & Hers, it means the COO’s 97,289-share sale was planned ahead, making the timing less indicative of a discretionary view on the stock.